Analyzing venous thromboembolism risk in malignant tumors: thromboelastogram and coagulation factors study

Biomark Med. 2024;18(8):373-383. doi: 10.1080/17520363.2024.2342239. Epub 2024 Jun 4.

Abstract

Aim: This retrospective clinical study was designed to examine the predictive value of thromboelastography (TEG) combined with coagulation function for venous thromboembolism (VTE) in hospitalized patients with cancer. Materials & methods: Among 215 patients admitted between May 2020 and January 2022, 39 (18.14%) were diagnosed with VTE during hospitalization. Results: Significant differences were found in D-dimer, ATIII and TEG parameters (maximum amplitude and coagulation index) between VTE-positive and VTE-negative patients (p < 0.05). Multivariate analysis revealed tumor node metastasis stage, concomitant infection, smoking history and D-dimer as independently associated with VTE. The constructed model and D-dimer areas under the curve were 0.809 and 0.764, respectively. Conclusion: TEG parameters were not significantly predictive indicators for VTE, with D-dimer remaining a key predictor.

Keywords: D-dimer; forecast; neoplasms; thrombelastography; thromboembolism; venous.

Plain language summary

[Box: see text].

MeSH terms

  • Adult
  • Aged
  • Blood Coagulation Factors / analysis
  • Blood Coagulation Factors / metabolism
  • Female
  • Fibrin Fibrinogen Degradation Products* / analysis
  • Fibrin Fibrinogen Degradation Products* / metabolism
  • Humans
  • Male
  • Middle Aged
  • Neoplasms* / blood
  • Neoplasms* / complications
  • Retrospective Studies
  • Risk Factors
  • Thrombelastography*
  • Venous Thromboembolism* / blood
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / etiology

Substances

  • fibrin fragment D
  • Fibrin Fibrinogen Degradation Products
  • Blood Coagulation Factors